Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Minassian%2C+Angela+M%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (26)
1
Impact of a blood-stage vaccine on
Plasmodium vivax
malaria
enthalten in:
bioRxiv.org
| 2024
von
Hou, M.
|
Barrett, J.
|
Themistocleous, Y.
| +32
Wird geladen...
2
The predictive role of symptoms in COVID-19 diagnostic models : A longitudinal insight
enthalten in:
Epidemiology and infection
| 2024
von
Bird, O.
|
Galiza, E.
|
Baxter, D.
| +35
Wird geladen...
3
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3) : A randomised controlled trial
enthalten in:
The Journal of infection
| 2023
von
Kelly, E.
|
Greenland, M.
|
de Whalley, P.
| +31
Wird geladen...
4
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial
enthalten in:
The Journal of infection
| 2023
von
Liu, X.
|
Munro, A.
|
Wright, A.
| +59
Wird geladen...
5
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511
enthalten in:
The Journal of infection
| 2023
von
Liu, X.
|
Munro, A.
|
Feng, S.
| +56
ErratumFor: J Infect. 2022 Jun;84(6):795-813. - PMID 35405168
Wird geladen...
6
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial
enthalten in:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
| 2023
von
Heath, P.
|
Galiza, E.
|
Baxter, D.
| +42
Wird geladen...
7
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST) : a multicentre, blinded, phase 2, randomised trial
enthalten in:
The Lancet. Infectious diseases
| 2022
von
Munro, A.
|
Feng, S.
|
Janani, L.
| +153
CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1092-1093. - PMID 35550263
Wird geladen...
8
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial
enthalten in:
The Journal of infection
| 2022
von
Liu, X.
|
Munro, A.
|
Feng, S.
| +56
CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358
Wird geladen...
9
Impact of a blood-stage vaccine on Plasmodium vivax malaria
enthalten in:
medRxiv : the preprint server for health sciences
| 2022
von
Hou, M.
|
Barrett, J.
|
Themistocleous, Y.
| +32
UpdateIn: Sci Transl Med. 2023 Jul 12;15(704):eadf1782. - PMID 37437014
Wird geladen...
10
Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant
enthalten in:
bioRxiv.org
| 2022
von
Heath, P.
|
Galiza, E.
|
Baxter, D.
| +42
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
8
Lancet (London, England)
4
The Journal of infection
3
Nature medicine
3
bioRxiv.org
1
Clinical infectious diseases : an official publ...
1
Epidemiology and infection
1
Nature communications
1
The Lancet. Infectious diseases
1
The Lancet. Respiratory medicine
1
The New England journal of medicine
1
The lancet. HIV
1
medRxiv : the preprint server for health sciences
Alle anzeigen ...
weniger ...
Thema
19
COVID-19 Vaccines
19
Journal Article
18
Research Support, Non-U.S. Gov't
14
Randomized Controlled Trial
13
B5S3K2V0G8
13
ChAdOx1 nCoV-19
10
Clinical Trial, Phase II
10
Multicenter Study
8
Antibodies, Viral
6
Clinical Trial, Phase III
6
Immunoglobulin G
5
BNT162 Vaccine
4
Antibodies, Neutralizing
3
2SCD8Q63PF
3
COVID-19
3
N38TVC63NU
3
NVX-CoV2373 adjuvated lipid nanoparticle
3
SARS-CoV-2
3
Viral Vaccines
2
Clinical Trial, Phase I
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2024
4
2023
6
2022
13
2021
1
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...